Diagnostic Kit Development
Solutions
Online Inquiry

Diagnostic Kit Development

Diagnostic kits play an important role in the accurate detection and identification of infectious diseases. Our company is dedicated to the development of high-quality diagnostic kits specifically designed for infectious diseases. Partnering with us, you will receive comprehensive support throughout the entire journey of diagnostic research to commercialization.

Overview of Infectious Disease Diagnostic Kits

Infectious disease diagnostic kits are efficient and accurate diagnostic tools used to identify the pathogens causing infections, providing a basis for selecting appropriate therapeutic strategies. These kits offer several advantages over traditional diagnostic methods.

Rapid Detection

Diagnostic kits facilitate the rapid detection of pathogens, enabling early intervention and preventing further transmission.

Quantitative Results

Infectious disease diagnostic kits provide quantitative results, aiding in disease staging and monitoring therapeutic effectiveness.

Precision Therapy

The use of diagnostic kits also contributes to precision therapy, minimizing antibiotic misuse and the development of antibiotic resistance.

Scientists are testing blood samples from infected patients using antigen detection kits.Fig. 1 Antigen detection kits.

Approved Infectious Disease Diagnostic Kits

In the landscape of infectious disease diagnostic kits, several products have obtained regulatory approval and demonstrated their efficacy in detecting and managing specific infections.

Kits Detection Targets Detection Methods
Influenza Diagnostic Kit Hemagglutinin (HA) and neuraminidase (NA) PCR
HIV Rapid Diagnostic Kit HIV-specific antibodies, p24 antigen Lateral flow immunoassays
Hepatitis B Diagnostic Kit HBV surface antigen (HBsAg) Serological assays
Tuberculosis (TB) Diagnostic Kit Antigenic target 6 (ESAT-6) PCR
COVID-19 Diagnostic Kit Nucleocapsid protein (N) and the spike protein (S) PCR

Our Services

Diagnostic kits play a crucial role in the early detection and identification of pathogens responsible for infectious diseases. With rich experience and expertise, our company has established a strict and meticulous development process for infectious disease diagnostic kit development.

Workflow of Diagnostic Kit Development

Target Identification

We employ a multidisciplinary approach, leveraging cutting-edge technologies and collaborating with leading experts in the field to identify the most suitable targets for diagnostic kit development.

Prototype Development

This phase involves the selection and integration of various components, such as capture molecules, detection probes, and sample preparation reagents, into a user-friendly and cost-effective format.

Preclinical Evaluation

Our scientists utilize animal models to perform preclinical studies. These studies assess the diagnostic stability and specificity of the kits in real-world scenarios, guiding any necessary improvements.

Assay Design

Our company excels in assay design and can use various detection methods such as PCR, immunoassay, biosensor, etc. This depends on the pathogen type, sample availability and sensitivity requirements.

Optimization and Validation

Our company conducts extensive optimization experiments to optimize assay conditions, including incubation time, temperature, and sample volume, aiming to achieve the best possible sensitivity and specificity.

Optional Diagnostic Kit Types

We can develop corresponding diagnostic kits for various biomarkers specific to infectious diseases to meet your research needs.

  • Antigen Detection Kit
  • Antibody Detection Kit
  • Nucleic Acid Detection Kit
  • Metabolite Detection Kit
  • Microbial Detection Kit
  • And More

Applicable Infectious Disease Types

Our diagnostic kits are applicable to a variety of infectious disease types and can meet all your needs in diagnostic development.

If you are interested in our services, please feel free to contact us for more details and quotation information of related services.

References

  1. Taryma-Leśniak O, Sokolowska K E, Wojdacz T K. Current status of development of methylation biomarkers for in vitro diagnostic IVD applications[J]. Clinical epigenetics, 2020, 12(1): 100.
  2. Mugambi M L, Peter T, Martins S F, et al. How to implement new diagnostic products in low-resource settings: an end-to-end framework[J]. BMJ global health, 2018, 3(6): e000914.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.